FR2929518B1 - Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane - Google Patents

Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Info

Publication number
FR2929518B1
FR2929518B1 FR0852277A FR0852277A FR2929518B1 FR 2929518 B1 FR2929518 B1 FR 2929518B1 FR 0852277 A FR0852277 A FR 0852277A FR 0852277 A FR0852277 A FR 0852277A FR 2929518 B1 FR2929518 B1 FR 2929518B1
Authority
FR
France
Prior art keywords
appendix
proteins
treatment
skin aging
cosmetic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0852277A
Other languages
English (en)
Other versions
FR2929518A1 (fr
Inventor
Dominique Bernard
Lucie Simonetti
Isabelle Castiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0852277A priority Critical patent/FR2929518B1/fr
Publication of FR2929518A1 publication Critical patent/FR2929518A1/fr
Application granted granted Critical
Publication of FR2929518B1 publication Critical patent/FR2929518B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0852277A 2008-04-04 2008-04-04 Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane Expired - Fee Related FR2929518B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0852277A FR2929518B1 (fr) 2008-04-04 2008-04-04 Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0852277A FR2929518B1 (fr) 2008-04-04 2008-04-04 Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Publications (2)

Publication Number Publication Date
FR2929518A1 FR2929518A1 (fr) 2009-10-09
FR2929518B1 true FR2929518B1 (fr) 2013-06-28

Family

ID=39864833

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0852277A Expired - Fee Related FR2929518B1 (fr) 2008-04-04 2008-04-04 Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Country Status (1)

Country Link
FR (1) FR2929518B1 (fr)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0496434B1 (fr) * 1987-10-22 1999-02-03 The Procter & Gamble Company Compositions photoprotectrices contenant des agents chélatants
DE10100121A1 (de) * 2001-01-03 2002-08-01 Henkel Kgaa Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro
US7547454B2 (en) * 2002-11-07 2009-06-16 Shyam K Gupta Hydroxy acid complexes for antiaging and skin renovation
WO2004080424A2 (fr) * 2003-03-13 2004-09-23 The Brigham And Women's Hospital, Inc. Methodes et compositions permettant de detecter une excroissance de neurite
US20050152862A1 (en) * 2003-10-29 2005-07-14 L'oreal Cosmetic peeling method
WO2006018198A1 (fr) * 2004-08-13 2006-02-23 Henkel Kommanditgesellschaft Auf Aktien Compositions cosmetiques et dermatologiques a base de (2-hydroxyethyl)uree
FR2878438B1 (fr) * 2004-11-26 2009-07-03 Oreal Composition cosmetique comprenant un agent tenseur et une hydroxyalkyl uree
KR101165848B1 (ko) * 2005-08-18 2012-07-13 (주)아모레퍼시픽 효소 및 아미노산을 함유하는 피부 화장료 조성물
JP5362219B2 (ja) * 2005-08-23 2013-12-11 株式会社ファンケル 皮膚老化マーカーとその利用技術
FR2898046A1 (fr) * 2006-03-03 2007-09-07 Oreal Emulsion contenant de hydroxyacides
JP4675806B2 (ja) * 2006-03-16 2011-04-27 日本メナード化粧品株式会社 アネキシン活性化剤
FR2903303B1 (fr) * 2006-07-07 2011-12-09 Labo Dermatologiques D'uriage Compositions dermatologiques et/ou cosmetologiques destinees a lutter contre le vieillissement cutane

Also Published As

Publication number Publication date
FR2929518A1 (fr) 2009-10-09

Similar Documents

Publication Publication Date Title
CY2020043I1 (el) Παγιδες gdf για χρηση στη θεραπευτικη αντιμετωπιση της αναιμιας
FR2925312B1 (fr) Utilisation cosmetique de proteines de type desmogleine i
FR2924946B1 (fr) Utilisation cosmetique de proteines de type ceramidase acide
BRPI0912402A2 (pt) processos e kit de tratamento dos cabelos
IL259547B (en) Isolated protein and preparations containing it for use in the treatment of disorders caused by il-1
FR2924947B1 (fr) Utilisation cosmetique de proteines de type calmodulin-like skin protein clsp
FR2948016B1 (fr) Orthese pour le traitement de la rhizarthrose
BR112013009589A2 (pt) composição de cuidados com o cabelo
FR2917629B1 (fr) Utilisation cosmetique de proteines de type apolipoproteine d
FR2924613B1 (fr) Utilisation cosmetique de proteines de type hsp27.
FR2974297B1 (fr) Nouvelle utilisation cosmetique ou therapeutique du tripeptide ghk
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
BRPI1014159A2 (pt) cosmético capilar
FR2948687B1 (fr) Utilisation de microarn pour le traitement de pathologies respiratoires chroniques
HK1158099A1 (en) Hair dressing cosmetic
FR2992173B1 (fr) Procece cosmetique d'eclaircissement de la peau et/ou des levres
FR2925314B1 (fr) Utilisation cosmetique de proteines de type transglutaminase 3
FR2920309B1 (fr) Utilisation de travoprost pour traiter la chute des cheveux
BR112012006005A2 (pt) "peptídeos no tratamento de transtorno associados ao estresse oxidativo"
BR112013012262A2 (pt) cosmético de cabelo
FR2938762B1 (fr) Utilisation cosmetique de proteines de type dj-1 pour le traitement de la secheresse cutanee
FR2932986B1 (fr) Composition regeneratrice de la peau
BR112015006272A2 (pt) ''uso cosmético, composto, composição cosmética e método de tratamento cosmético''
FR2948877B1 (fr) Composition pour la protection et la regeneration de la peau
FR2929518B1 (fr) Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20161230